INS and type 2 diabetes mellitus: DHM has been extensively studied in vivo; it reduces thrombus formation induced by FeCl3, and its effects on glycemic control and insulin sensitivity in patients with type 2 diabetes are currently being evaluated in phase II clinical trials (NCT03606694) [57].